Funding for this research was provided by:
Versus Arthritis : 20372
Versus Arthritis : 20834
Text and Data Mining valid from 2020-01-09
Received: 5 April 2019
Accepted: 2 December 2019
First Online: 9 January 2020
: S.E.C. is employed by MedImmune/AstraZeneca. She provided ST2-Fc and control mouse IgG1 reagents, as well as scientific input in the design of the related experiment. The remaining authors declare no competing financial interests.